查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813927

HIV自我檢測市場規模、佔有率和趨勢分析報告：按類型、技術、分銷管道、地區和細分市場預測，2025-2033年

HIV Self-testing Market Size, Share & Trends Analysis Report By Type (Blood-based Kits, Saliva-based Kits), By Technology (Immunofiltration Assays, Lateral Flow Assays (LFA)), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

HIV自我檢測市場摘要

預計 2024 年全球愛滋病毒自我檢測市場規模為 2.1155 億美元，到 2033 年將達到 6.4341 億美元，2025 年至 2033 年的複合年成長率為 13.55%。

這項成長的促進因素是：人們越來越重視早期愛滋病毒檢測、愛滋病毒感染率不斷上升，以及全球轉向個人和保密的健康解決方案。

超過 100 個國家已經採取了 HIVST 政策，光是在 2023 年，全球就分發了超過 2,000 萬套套件。快速診斷試劑套件價格實惠且擴充性，使其成為已開發國家和開發中國家衛生系統中必不可少的物品。根據最新估計，全球約有 4,080 萬人感染愛滋病毒，其中包括 140 萬名 0-14 歲兒童。光是 2024 年，就會有大約 130 萬人新發生愛滋病毒感染，其中 12 萬名為兒童。同年，估計將有 63 萬人死於愛滋病毒相關原因，其中包括 7.5 萬名兒童。自愛滋病毒流行以來，估計已有 4,410 萬人死於愛滋病毒相關疾病。儘管影響持續存在，但過去十五年全球已取得長足進展。 2010年至2024年間，愛滋病毒新發感染人數下降了約40%，從每年220萬例降至130萬例。同期，愛滋病毒相關死亡人數下降了54%，從140萬例降至63萬例。這些下降反映了人們認知的提高和預防工作的加強、抗逆轉錄病毒療法可及性的擴大，以及愛滋病毒自我檢測等策略的採用，從而實現了更早的診斷和治療。

HIV 自我檢測市場強勁成長的驅動力之一是，人們對謹慎、便捷且易於使用的診斷方案的需求日益成長，尤其是在那些面臨污名化和難以獲得臨床檢測的人群中。根據聯合國愛滋病規劃署的數據，全球近 40% 的 HIV 感染者仍未被確診，這主要是由於害怕歧視、社會污名化以及醫療資源匱乏。 HIV 自我檢測提供了一種個人化的居家檢測方案，使個人能夠安心地了解自己的感染狀況。像 OraQuick 家用 HIV 檢測試劑盒這樣的唾液檢測套件因其非侵入性、簡單性和 20 分鐘即可出結果而廣受歡迎。在 HIV 感染率最高的地區，例如撒哈拉以南非洲地區，自我檢測至關重要。肯亞、馬拉威和南非等國家已透過社區和非政府組織的推廣，擴大了其國家 HIVST 計畫。在高所得國家，電子商務的日益普及使得 HIV 自我檢測可以透過線上藥局廣泛進行。這種匿名性、便利性和技術簡易性的結合不僅提高了診斷率，而且從根本上改變了公共衛生系統處理愛滋病毒預防和治療聯繫的方式。

科技進步正在將愛滋病毒自檢轉變為更準確、更有效率、更以使用者為中心的流程。最常見的方法是側流免疫檢測(LFA)，它使用簡單的試紙條從唾液或指尖採血樣本中檢測 HIV-1/2 抗體。這些檢測方法可在 15-20 分鐘內提供結果，而像 Atomo 的愛滋病毒自檢儀這樣的新設備則將採血針、緩衝液和試紙條等一體化整合系統整合在一個裝置中。此外，與智慧型手機相連的數位自我檢測儀正在試行中，使用者可以掃描結果、接收指導說明並使用遠端醫療服務。臨床試驗顯示，基於智慧型手機的讀數與經過訓練的目測判讀的一致性超過 98%。此外，微流體和奈米檢測的創新有望使未來的愛滋病毒檢測試劑套件更加靈敏，並能更好地適應早期感染。該行業也正在轉向組合試劑套件（例如，愛滋病毒 + 梅毒），尤其是在合併感染率高的地區。這種技術改進不僅可以減少人為錯誤，還可以使低識字率人群進行自我測試，進一步擴大全球採用率。

目錄

第 1 章 HIV 自我檢測市場：調查方法與範圍

2. HIV自我檢測市場：執行摘要

  • 市場概述
  • 類型和技術簡介
  • 分銷通路簡介
  • 競爭格局簡介

第3章 HIV 自我檢測市場變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
  • 市場促進因素分析
    • 提高愛滋病毒認知和政府舉措
    • 對隱私和便利性有很高的要求
    • 檢測套組的技術進步
  • 市場限制因素分析
    • 監管和核准挑戰
    • 誤用或誤解的風險
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第4章：HIV自我檢測市場：類型評估與趨勢分析

  • HIV自我檢測市場：類型變化分析
  • 血液試劑套件
  • 唾液試劑套件

第5章 HIV 自我檢測市場：技術評估與趨勢分析

  • HIV自我檢測市場：技術變革分析
  • 免疫過濾試驗
  • 橫向流動化驗（LFA）
  • 其他快速診斷技術

6. HIV自我檢測市場：通路評估與趨勢分析

  • HIV自我檢測市場：通路變化分析
  • 零售及網路藥局
  • 醫院和診斷實驗室
  • 非政府組織/社區分銷

7. HIV自我檢測市場：區域業務分析

  • 區域市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第8章 競爭態勢

  • 公司分類
  • 戰略地圖
    • 新產品發布
    • 夥伴關係
    • 獲得
    • 合作
    • 資金籌措
  • 2024年主要企業市佔率分析
  • 公司熱圖分析
  • 公司簡介
    • OraSure Technologies, Inc.
    • BioSURE HIVST
    • Atomo Diagnostics
    • Chembio Diagnostics, Inc.
    • SD Biosensor, INC.
    • CTK Biotech, Inc.
    • genedrive plc
    • Hydrex Diagnostics Sp.
    • Trinity Biotech
    • Abbott
Product Code: GVR-4-68040-710-7

HIV Self-testing Market Summary

The global HIV Self-testing market size was estimated at USD 211.55 million in 2024 and is expected to reach USD 643.41 million by 2033, growing at a CAGR of 13.55% from 2025 to 2033. This growth is fueled by an increasing emphasis on early HIV detection, rising HIV prevalence, and a global shift toward personal, confidential health solutions.

Over 100 countries have adopted HIVST policies, and more than 20 million kits were distributed globally in 2023 alone. The affordability and scalability of rapid diagnostic kits have made them integral in both developed and developing health systems. As of the most recent estimates, approximately 40.8 million people worldwide are living with HIV, including 1.4 million children between the ages of 0 and 14. In 2024 alone, there were about 1.3 million new HIV infections, with 120,000 cases occurring in children. That same year, an estimated 630,000 people died from HIV-related causes, including 75,000 children. Since the beginning of the HIV epidemic, it is estimated that 44.1 million people have lost their lives due to HIV-related illnesses. Despite the ongoing impact, global progress has been substantial over the past decade and a half. Between 2010 and 2024, the number of new HIV infections decreased by approximately 40%, dropping from 2.2 million to 1.3 million annually. During the same period, HIV-related deaths fell by 54%, declining from 1.4 million to 630,000. These reductions reflect the success of widespread awareness, prevention efforts, antiretroviral therapy scale-up, and increasing adoption of strategies such as HIV self-testing, which have contributed to earlier diagnosis and treatment initiation.

One of the strongest drivers of the HIV self-testing market is the rising demand for discreet, accessible, and user-friendly diagnostic options, particularly in populations facing stigma or barriers to clinic-based testing. According to UNAIDS, nearly 40% of people living with HIV globally remain undiagnosed, a gap largely attributed to fear of discrimination, social stigma, and inconvenient access to health facilities. HIV self-tests provide a private, at-home alternative that empowers individuals to know their status without fear. Saliva-based kits such as OraQuick In-Home HIV Test have become popular for their non-invasive nature, simplicity, and 20-minute result window. In regions such as Sub-Saharan Africa, where HIV prevalence is highest, self-testing has been pivotal: countries like Kenya, Malawi, and South Africa have scaled up national HIVST programs through community and NGO distribution. In high-income countries, rising e-commerce penetration has enabled widespread access to HIV self-tests via online pharmacies. This combination of anonymity, convenience, and technological simplicity is not only improving diagnosis rates but also fundamentally shifting how public health systems approach HIV prevention and treatment linkage.

Technological advancements are transforming HIV self-testing into a more accurate, efficient, and user-centric process. The most common format-lateral flow immunoassays (LFA)-uses a simple strip that detects HIV-1/2 antibodies through a saliva or finger-prick blood sample. These tests deliver results in 15-20 minutes, and newer devices incorporate all-in-one integrated systems, such as Atomo's HIV Self-Test, which combines lancet, buffer, and strip in a single device. In addition, smartphone-linked digital self-tests are being piloted, allowing users to scan results, receive guided instructions, and access telehealth services-enhancing test reliability and post-test linkage to care. In clinical trials, smartphone-based readers have shown >98% concordance with trained visual interpretation. Furthermore, innovations in microfluidics and nano-based detection promise to make future HIVST kits even more sensitive and early-stage infection-aware. The industry is also shifting toward combination kits (e.g., HIV + syphilis), especially in areas with co-infection burdens. These technological improvements not only reduce human error but also make self-testing viable in low-literacy populations, further expanding its global reach.

Global HIV Self-testing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global HIV self-testing market based on type, technology, distribution channel, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Blood-based Kits
  • Saliva-based Kits
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Immunofiltration Assays
  • Lateral Flow Assays (LFA)
  • Other Rapid Diagnostic Technologies
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Retail and Online Pharmacies
  • Hospitals and Diagnostics Laboratories
  • NGO/ Community-based Distribution
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. HIV Self-testing Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Type Segment
      • 1.1.1.2. Technology Segment
      • 1.1.1.3. Sample Type segment
      • 1.1.1.4. Distribution Channel Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. HIV Self-testing Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type and Technology Snapshot
  • 2.3. Distribution Channel Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. HIV Self-testing Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising HIV awareness and government initiatives
    • 3.4.2. High demand for privacy and convenience
    • 3.4.3. Technological advancements in test kits
  • 3.5. Market Restraint Analysis
    • 3.5.1. Regulatory and approval challenges
    • 3.5.2. Risk of misuse or misinterpretation
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. HIV Self-testing Market: Type Estimates & Trend Analysis

  • 4.1. HIV Self-testing Market: Type Movement Analysis
  • 4.2. Blood-based Kits
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Saliva-based Kits
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. HIV Self-testing Market: Technology Estimates & Trend Analysis

  • 5.1. HIV Self-testing Market: Technology Movement Analysis
  • 5.2. Immunofiltration Assays
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Lateral Flow Assays (LFA)
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Other Rapid Diagnostic Technologies
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. HIV Self-testing Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. HIV Self-testing Market: Distribution Channel Movement Analysis
  • 6.2. Retail and Online Pharmacies
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Hospitals and Diagnostics Laboratories
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. NGO/Community-Based Distribution
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. HIV Self-testing Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America HIV Self-testing Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Reimbursement Scenario
      • 7.2.2.5. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Reimbursement Scenario
      • 7.2.3.5. Competitive Scenario
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.2.4.2. Key Country Dynamics
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Reimbursement Scenario
      • 7.2.4.5. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe HIV Self-testing Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Reimbursement Scenario
      • 7.3.5.5. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Reimbursement Scenario
      • 7.3.6.5. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Reimbursement Scenario
      • 7.3.7.5. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Reimbursement Scenario
      • 7.3.8.5. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Reimbursement Scenario
      • 7.3.9.5. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific HIV Self-testing Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America HIV Self-testing Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Competitive Scenario
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Competitive Scenario
  • 7.6. MEA
    • 7.6.1. MEA HIV Self-testing Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait HIV Self-testing Market, 2021 - 2033 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. OraSure Technologies, Inc.
      • 8.5.2.1. Company Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. BioSURE HIVST
      • 8.5.3.1. Company Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Atomo Diagnostics
      • 8.5.4.1. Company Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Chembio Diagnostics, Inc.
      • 8.5.5.1. Company Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. SD Biosensor, INC.
      • 8.5.6.1. Company Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. CTK Biotech, Inc.
      • 8.5.7.1. Company Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. genedrive plc
      • 8.5.8.1. Company Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Hydrex Diagnostics Sp.
      • 8.5.9.1. Company Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Trinity Biotech
      • 8.5.10.1. Company Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Abbott
      • 8.5.11.1. Company Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviation
  • Table 3 Global HIV Self-testing Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 5 Global HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 6 Global HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 7 North America HIV Self-testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 8 North America HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 9 North America HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 10 North America HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 11 U.S. HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 12 U.S. HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 13 U.S. HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 14 Canada HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 15 Canada HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 16 Canada HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 17 Mexico HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 18 Mexico HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 19 Mexico HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 20 Europe HIV Self-testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 21 Europe HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 22 Europe HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 23 Europe HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 24 UK HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 25 UK HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 26 UK HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 27 Germany HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 28 Germany HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 29 Germany HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 30 France HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 31 France HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 32 France HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 33 Italy HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 34 Italy HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 35 Italy HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 36 Spain HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 37 Spain HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 38 Spain HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 39 Sweden HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 40 Sweden HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 41 Sweden HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 42 Norway HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 43 Norway HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 44 Norway HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 45 Denmark HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 46 Denmark HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 47 Denmark HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific HIV Self-testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 52 Japan HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 53 Japan HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 54 Japan HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 55 China HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 56 China HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 57 China HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 58 India HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 59 India HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 60 India HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 61 Australia HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 62 Australia HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 63 Australia HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 64 Thailand HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 65 Thailand HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 66 Thailand HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 67 South Korea HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 68 South Korea HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 69 South Korea HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 70 Latin America HIV Self-testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 71 Latin America HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 72 Latin America HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 73 Latin America HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 74 Brazil HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 75 Brazil HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 76 Brazil HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 77 Argentina HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 78 Argentina HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 79 Argentina HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 80 MEA HIV Self-testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 81 MEA HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 82 MEA HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 83 MEA HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 84 South Africa HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 85 South Africa HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 86 South Africa HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 90 UAE HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 91 UAE HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 92 UAE HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 93 Kuwait HIV Self-testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 94 Kuwait HIV Self-testing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 95 Kuwait HIV Self-testing Market, By Distribution Channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global HIV self-testing market- Key market driver analysis
  • Fig. 7 Global HIV self-testing market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global HIV self-testing market - Porter's analysis
  • Fig. 10 Global HIV self-testing market - PESTEL analysis
  • Fig. 11 Global HIV self-testing market Type outlook key takeaways
  • Fig. 12 Global HIV self-testing market: Type movement analysis
  • Fig. 13 Blood-based kits market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Saliva-based kits market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 HSV-1 market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 HSV-2 market estimates, 2021 - 2033 (USD Million)
  • Fig. 17 Global HIV self-testing market technology outlook key takeaways
  • Fig. 18 Global HIV self-testing market: technology movement analysis
  • Fig. 19 Immunofiltration Assays market estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Lateral flow assays (LFA) market estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Other rapid diagnostic technologies market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Global HIV self-testing market distribution channel outlook key takeaways
  • Fig. 23 Global HIV self-testing market: distribution channel movement analysis
  • Fig. 24 Retail and online pharmacies market estimates, 2021 - 2033 (USD Million)
  • Fig. 25 Hospitals and diagnostics laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 26 NGO/Community-based distribution market estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 Global HIV Self-testing market: Regional movement analysis
  • Fig. 29 North America HIV Self-testing market, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 31 Canada HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 32 Mexico HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 33 Europe HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 34 UK HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 35 Germany HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 36 France HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 37 Spain HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 38 Italy HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 39 Denmark HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 40 Sweden HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 41 Norway HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 42 Asia Pacific HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 43 Japan HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 44 China HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 45 India HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 46 South Korea HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 47 Australia HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 48 Thailand HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 49 Latin America HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 50 Brazil HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 51 Argentina HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 52 MEA HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 53 South Africa HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 54 Saudi Arabia HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 55 UAE HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 56 Kuwait HIV self-testing market, 2021 - 2033 (USD Million)
  • Fig. 57 Strategy framework